|
|
|
|
|
searchin this issue
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Displaying 21 - 40 of 414 stories.
May 29, 2009
DSM says that studies done at its R&D labs show that its extreme density (XD) technology boosts bioreactor productivity and titers of mammalian cell culture processes for protein...http://www.chemweek.com/sections/pharma_and_fine_chemicals/DSM-Technology-Raises-Bioreactor-Productivity_19247.html May 29, 2009
Lonza says it has entered into a manufacturing services agreement with biopharmaceutical firm Morphotek (Exton, PA), to support the development and manufacturing of a subset of...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Lonza-Signs-Manufacturing-Agreement-with-U-S-Biopharma-Firm_19248.html May 29, 2009
Pharmaceutical intermediates and active pharma ingredients (API) manufacturer Minakem (Beuvry-la-Forêt, France) has completed the acquisition of a multi-purpose API plant at...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Minakem-Acquires-API-Plant-from-AstraZeneca_19249.html May 29, 2009
Roche has signed an agreement to purchase Codex Biocatalyst Panels, a biocatalysis-based research and manufacturing productivity product, from Codexis (Redwood City, CA), a developer...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Roche-Buys-Productivity-Product-from-Codex_19250.html May 22, 2009
Lonza says it will build a cell therapy facility in Singapore to expand its global presence and meet growing worldwide demand. Lonza will invest SF30 million ($27 million) in the...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Lonza-to-Build-Cell-Therapy-Production-Facility-in-Singapore_19099.html May 22, 2009
Contract manufacturing of active pharmaceutical ingredients (APIs) and finished dosage drug forms will grow in India at 30%-40%/year until 2013, says a new report from Frost &...http://www.chemweek.com/sections/pharma_and_fine_chemicals/India-to-Remain-a-Cost-Competitive-Hub_19100.html May 22, 2009
Cambrex (East Rutherford, NJ) reported first-quarter net profits up 12%, to $4.7 million compared with the year-ago period, on sales down by nearly 3%, to $60 million. Sales were...http://www.chemweek.com/sections/pharma_and_fine_chemicals/First-Quarter-Profits-Rise-at-Cambrex_19101.html May 11, 2009
Novozymes says it has broken ground on a facility to produce bacillus-based hyaluronic acid (bHA) at its existing Tianjin, China site. The company is also considering establishing a...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Novozymes-Breaks-Ground-in-China-for-Hyaluronic-Acid-Unit_18809.html May 8, 2009
Sanofi-Aventis (Paris) says it has started up the “Biolaunch project” at its Vitry-sur-Seine (France) pharmaceutical production site. The €200-million ($266 million)...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Sanofi-Aventis-to-Establish-Biotech-Facility-in-France_18810.html May 8, 2009
Pharmaceutical firm Strides Arcolab (Bangalore) says it has begun supplying Oseltamivir capsules, the generic equivalent of Roche’s Tamiflu, to various countries for swine flu...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Strides-Arcolab-to-Up-Production_18811.html May 8, 2009
Ranbaxy Pharmaceuticals, a Ranbaxy Laboratories (Gurgaon, India) subsidiary, says it has voluntarily recalled its antibiotic nitrofurantoin capsules from the U.S. market, as certain...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Ranbaxy-Recalls-Antibiotic-in-U-S-_18812.html May 8, 2009
Althea Technologies (San Diego), a biopharmaceutical development and manufacturing services supplier, says it has opened a commercial-scale cGMP facility for biologics and injectables...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Althea-Opens-San-Diego-Facility_18813.html May 1, 2009
Lonza has completed construction of a 2,000-liter microbial fermentation plant at its Hopkinton, MA site. The company says it has also revamped the site to enhance infrastructure...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Lonza-Revamps-U-S-Microbial-Fermentation-Site_18635.html May 1, 2009
Active pharmaceutical ingredient (API) manufacturer Hovione (Loures, Portugal) says it has opened an API manufacturing site at Cork, Ireland. Pfizer last month completed the hand over...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Hovione-Opens-API-Facility-in-Ireland_18636.html May 1, 2009
Sanofi-Aventis (Paris) says it will invest €31 million ($41 million) to build a facility at the Hangzhou Binjiang New Development Zone (Hangzhou, China), which will take on...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Sanofi-Aventis-to-Build-Pharma-Plant-in-China_18637.html April 24, 2009
GlaxoSmithKline (GSK) says it has signed an agreement to acquire dermatological product firm Stiefel Laboratories (Coral Gables, FL), for about $3.6 billion. The deal calls for GSK and...http://www.chemweek.com/sections/pharma_and_fine_chemicals/GSK-Inks-Deal-to-Buy-Stiefel-for-$3-6-billion_18479.html April 24, 2009
DSM says that its DSM Pharmaceutical Products custom manufacturing business unit has entered into a multimillion-dollar contract to make and supply pharmaceuticals for Shire US...http://www.chemweek.com/sections/pharma_and_fine_chemicals/DSM-to-Supply-Shire-US-Manufacturing_18480.html April 24, 2009
Sanofi-Aventis (Paris) says it has agreed to acquire Medley (Campinas, Brazil), Brazil’s largest generics drugmaker and third-largest pharmaceutical company, for about €500...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Sanofi-Aventis-to-Buy-Firms-in-Brazil-and-U-S-_18498.html April 24, 2009
Reaxa (Manchester, U.K.), a catalyst technology provider for pharmaceutical and fine chemical manufacturers, says it expects India to become one of its major markets in the next 12...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Indian-Market-to-Boost-Reaxas-Growth_18499.html April 10, 2009
Dishman Pharmaceuticals & Chemicals (Ahmedabad, India) says it has signed a cooperation and joint active pharmaceutical ingredient (API) development agreement with Polpharma...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Dishman-Signs-API-Development-Deal-with-Polish-Firm_18201.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
